See the latest news and media coverage for TidalSense. We track all announcements, press releases, and industry mentions in real time, all in one place.
AI-driven respiratory diagnostic and monitoring technology company
tidalsense.comLast updated
In short: TidalSense advanced its N-Tidal Diagnose tool through NHS rollouts, international clinical trials, and major funding for pediatric asthma research.
The paper analyzes N-Tidal capnography data from 147 COPD patients, revealing a non-linear correlation with smoking pack years and an inflection point at 25 pack years. Spirometry lacks similar sensitivity.
It offers rapid, accurate point-of-care diagnostics in 10 minutes training, 75 seconds breathing, and 5 minutes testing. They aim to transform respiratory care pathways.
Highlights include CE-marking for N-Tidal Diagnose, HQ expansion, NHS framework award, first uses, studies, international expansion, hires, conferences, and Global Health Innovator Award.
Clinical evaluation occurs with Dr. Sami Simons at Maastricht University Medical Centre+ in Netherlands. It marks a major milestone.
An AI chronic obstructive pulmonary disease (COPD) diagnostic tool is to be rolled out across the NHS, offering patients an alternative to traditional spirometry N-Tidal...
The device, known as N-Tidal Diagnose, uses carbon dioxide sensors to measure changes in a patient's lung function with results given in minutes. A test...
TidalSense has received a £795,000 grant from the UK's Small Business Research Initiative (SBRI) Healthcare programme to support the continued development of its N-Tidal device...
The N-Tidal device test takes under five minutes from breath to result Oxford clinicians will be the first to use a new AI-driven device for...
Track TidalSense and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to TidalSense and other trending companies.